![Trevor Ajan Reginald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Trevor Ajan Reginald
Founder at Oncogeni Ltd.
Trevor Ajan Reginald active positions
Companies | Position | Start | End |
---|---|---|---|
Desktop Genetics Ltd.
![]() Desktop Genetics Ltd. Packaged SoftwareTechnology Services Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm specializes in synthetic biology, genome engineering, genome editing, functional genomics, bioinformatics, and screening. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom. | Director/Board Member | 04/06/2018 | - |
Oncogeni Ltd.
![]() Oncogeni Ltd. BiotechnologyHealth Technology Part of Roquefort Therapeutics Plc, Oncogeni Ltd. operates as a British biotechnology company. The company is based in Stratford-upon-Avon, UK. The company was founded in 2019 by Nobel Laureate, Martin John Evans, Trevor Ajan Reginald. Oncogeni was acquired by Roquefort Therapeutics Plc on September 16, 2022 for $4.61 million. | Director/Board Member | 29/05/2019 | - |
Founder | 01/05/2019 | - |
Career history of Trevor Ajan Reginald
Statistics
International
United Kingdom | 3 |
Operational
Director/Board Member | 2 |
Founder | 1 |
Sectoral
Technology Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Desktop Genetics Ltd.
![]() Desktop Genetics Ltd. Packaged SoftwareTechnology Services Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm specializes in synthetic biology, genome engineering, genome editing, functional genomics, bioinformatics, and screening. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom. | Technology Services |
Oncogeni Ltd.
![]() Oncogeni Ltd. BiotechnologyHealth Technology Part of Roquefort Therapeutics Plc, Oncogeni Ltd. operates as a British biotechnology company. The company is based in Stratford-upon-Avon, UK. The company was founded in 2019 by Nobel Laureate, Martin John Evans, Trevor Ajan Reginald. Oncogeni was acquired by Roquefort Therapeutics Plc on September 16, 2022 for $4.61 million. | Health Technology |
- Stock Market
- Insiders
- Trevor Ajan Reginald
- Experience